What can cognitive psychology contribute to clinical practice? Our interest is in developing sensitive clinical tools for assessing a wide range of behaviour and cognition. Furthermore, we are researching the effects of cognitive impairments in the real world, in terms of practical activities of daily life and quality of life. Our group supports the cognitive screening of stroke patients across the Oxford region.
Our cognitive screening program in stroke gives rise to a multitude of research streams: from improving diagnostics for clinical use, addressing the predictive ability of short screening tests for long term outcomes and using the data for lesion-symptom analysis based on clinical admission scans.
The group aims to bring together the expertise of cognitive neuropsychologists, clinicians and allied health professionals including occupational therapists and clinical psychologists to better understand the impacts of cognitive deficits after stroke.
Current research projects include psychometric validations of new neuropsychological screening tools as well as detailed experimental tests of attention impairments and around broader measures for determining decisional autonomy as determined by the Mental Capacity Act. We are interested in investigating post-stroke cognitive recovery and decline (linking to vascular dementia) and determining which early characteristics (acute cognitive profile and acute clinical imaging) factors are predictive of cognitive and functional (real life) outcomes. Finally, many projects in the lab concern more fundamental investigations into lesion-symptom mapping of discrete cognitive abilities.
Dr Demeyere is funded by the Stroke Association and holds the Lord Leonard and Lady Estelle Wolfson Foundation Lectureship.